Ontario Institute for Cancer Research (OICR)
See the following -
The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research.
Through a novel open source approach the molecule has been made freely available to the cancer research community to help discover new therapeutic strategies for cancer patients sooner...Researchers from the Ontario Institute for Cancer Research (OICR) and the Structural Genomics Consortium (SGC) at the MaRS Discovery District in Toronto have developed a new drug prototype called OICR-9429 and made it freely available to the research community. Already research conducted by international groups using OICR-9429 has shown it to be effective in stopping cancer cell growth in breast cancer cell lines and a specific subtype of leukemia cells.
- Login to post comments
The Ontario Institute For Cancer Research Joins The Open Cloud Consortium
The Ontario Institute for Cancer Research (OICR) and the Open Cloud Consortium (OCC) announced today that they have entered into a multi-year agreement that brings OICR into the OCC. OICR will be involved with several OCC Working Groups, including the Open Science Data Cloud Working Group and the Biomedical Commons Cloud Working Group, to build systems for cancer genomics analysis and biomedical data sharing...
- Login to post comments